AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
Boehringer Ingelheim Standardizes Customer Data with Veeva Across 100 Countries
ByAinvest
Wednesday, Jul 23, 2025 7:18 am ET1min read
Boehringer Ingelheim, a top 20 biopharma company, has standardized customer data across 100+ countries using Veeva OpenData and Veeva Network. This will equip the company's teams with insights for engaging healthcare professionals and lay the foundation for AI use cases. The partnership aims to enhance customer engagement and drive coordinated interactions focused on patient outcomes.
Boehringer Ingelheim, a leading biopharmaceutical company, has standardized customer data across more than 100 countries using Veeva Systems' OpenData and Network solutions [1]. This strategic move aims to enhance customer engagement and lay the foundation for future AI-driven initiatives.The implementation of Veeva OpenData and Network will provide Boehringer Ingelheim's teams with accurate and comprehensive customer reference data, enabling them to engage healthcare professionals (HCPs) more effectively. By consolidating its data strategy into a single comprehensive solution, Boehringer Ingelheim is simplifying data management and building efficiencies. This standardization ensures fast access to consistent, high-quality customer data across teams and regions, thereby improving cross-team collaboration [2].
The integration with Veeva Vault CRM will be streamlined through native OpenData and Network connections, supporting Boehringer's commercial excellence and AI initiatives. According to Kilian Weiss, senior vice president of Data Cloud International at Veeva, "Together, Vault CRM, OpenData, and Network deliver an integrated solution that connects data, enhances HCP engagement, and drives AI innovation at scale" [3].
The partnership highlights Veeva's successful cross-selling strategy and the stickiness of its ecosystem. By adopting multiple integrated Veeva products, Boehringer Ingelheim increases its switching costs, creating long-term recurring revenue opportunities for Veeva. This deal further entrenches Veeva's position in the life sciences data ecosystem, particularly as companies build foundations for AI implementation [2].
References:
[1] https://www.prnewswire.com/news-releases/veeva-opendata-and-veeva-network-enable-coordinated-customer-engagement-for-boehringer-ingelheim-302510644.html
[2] https://www.stocktitan.net/news/VEEV/veeva-open-data-and-veeva-network-enable-coordinated-customer-ashzhfati9wd.html
[3] https://www.morningstar.com/news/pr-newswire/20250723sf34486/veeva-opendata-and-veeva-network-enable-coordinated-customer-engagement-for-boehringer-ingelheim
Ainvest News articles are AI-generated using advanced large language model (LLM) technology designed to analyze and synthesize publicly available data and news. While AI tools assist in producing initial drafts and insights, all AI generated content published on Ainvest is subject to comprehensive human editorial review before publication. A designated human editor reviews, verifies, and approves each article for factual accuracy, coherence, and compliance with AInvest Fintech Inc’s editorial and disclosure standards.
Despite these review procedures, the information provided may still contain inaccuracies, incomplete data, or time sensitive references due to the inherent limitations of AI generated analysis and evolving changes. The material is provided strictly for informational and educational purposes and does not constitute personalized investment, legal, or financial advice. Readers should independently verify all facts, figures, and statements before making any decision based on this content.
AInvest Fintech Inc. its affiliates, and partners accept no liability or responsibility for any direct or consequential losses arising from reliance on this content. All articles and analyses are subject to revision, update, or removal without prior notice to maintain accuracy and integrity in our publications.
Comments
No comments yet